Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine

In the previous research at Jessenius Faculty of Medicine in Martin has been studied depression and its treatment from the aspects of the quality of life and functioning of the patients, as well as comparing the efficacy and safety of venlafaxine versus venlafaxine and olanzapine treatment. Last yea...

Full description

Bibliographic Details
Main Authors: Oppa M., Kulhan T., Nosáľová G., Ondrejka I.
Format: Article
Language:English
Published: Sciendo 2016-09-01
Series:European Pharmaceutical Journal
Subjects:
Online Access:https://doi.org/10.1515/afpuc-2016-0008
id doaj-ba05962663ee4304b2f7d357feaf7455
record_format Article
spelling doaj-ba05962663ee4304b2f7d357feaf74552021-09-06T19:39:44ZengSciendoEuropean Pharmaceutical Journal2453-67252016-09-01631252810.1515/afpuc-2016-0008afpuc-2016-0008Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of MedicineOppa M.0Kulhan T.1Nosáľová G.2Ondrejka I.3Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Clinic of Psychiatry, Martin SlovakiaComenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Clinic of Psychiatry, Martin, SlovakiaComenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Department of Pharmacology, Martin SlovakiaComenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Clinic of Psychiatry, Martin, SlovakiaIn the previous research at Jessenius Faculty of Medicine in Martin has been studied depression and its treatment from the aspects of the quality of life and functioning of the patients, as well as comparing the efficacy and safety of venlafaxine versus venlafaxine and olanzapine treatment. Last years have been studied the parameters of the autonomic nervous system in the context of depression. Our new work will build on these findings, during the exploration of efficacy and safety of a novel antidepressant vortioxetine in monotherapy and in combination with olanzapine. Since combination of vortixetine and olanzapine is not yet understood, it is unknown whether the effect of the treatment of depressive symptoms and associated problems will be stronger and faster compared to vortioxetine monotherapy.https://doi.org/10.1515/afpuc-2016-0008vortioxetineolanzapinedepression
collection DOAJ
language English
format Article
sources DOAJ
author Oppa M.
Kulhan T.
Nosáľová G.
Ondrejka I.
spellingShingle Oppa M.
Kulhan T.
Nosáľová G.
Ondrejka I.
Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
European Pharmaceutical Journal
vortioxetine
olanzapine
depression
author_facet Oppa M.
Kulhan T.
Nosáľová G.
Ondrejka I.
author_sort Oppa M.
title Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
title_short Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
title_full Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
title_fullStr Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
title_full_unstemmed Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
title_sort acute phase of depression treatment - current research and its perspectives on jessenius faculty of medicine
publisher Sciendo
series European Pharmaceutical Journal
issn 2453-6725
publishDate 2016-09-01
description In the previous research at Jessenius Faculty of Medicine in Martin has been studied depression and its treatment from the aspects of the quality of life and functioning of the patients, as well as comparing the efficacy and safety of venlafaxine versus venlafaxine and olanzapine treatment. Last years have been studied the parameters of the autonomic nervous system in the context of depression. Our new work will build on these findings, during the exploration of efficacy and safety of a novel antidepressant vortioxetine in monotherapy and in combination with olanzapine. Since combination of vortixetine and olanzapine is not yet understood, it is unknown whether the effect of the treatment of depressive symptoms and associated problems will be stronger and faster compared to vortioxetine monotherapy.
topic vortioxetine
olanzapine
depression
url https://doi.org/10.1515/afpuc-2016-0008
work_keys_str_mv AT oppam acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine
AT kulhant acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine
AT nosalovag acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine
AT ondrejkai acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine
_version_ 1717770174859313152